StockData
RenovoRx, Inc. logo

RenovoRx, Inc. (RNXT) stock

RNXTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.12+0.08 (+7.69%)

Close on Nov 18, 2026Market cap $50.55MP/E –Yield –

RenovoRx net income

Net income is the profit left for shareholders after every expense, interest and tax.

RenovoRx's net income for the twelve months ending Jun 30, 2026 was -$12.29M. For fiscal 2025 it was -$11.17M. The highest annual figure on record is -$3.80M in fiscal 2020.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$11.17M–
FY2024Dec 31, 2024-$8.81M–
FY2023Dec 31, 2023-$10.23M–
FY2022Dec 31, 2022-$9.89M–
FY2021Dec 31, 2021-$6.32M–
FY2020Dec 31, 2020-$3.80M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.91M–
Q1 FY2026Mar 31, 2026-$3.52M–
Q4 FY2025Dec 31, 2025-$2.94M–
Q3 FY2025Sep 30, 2025-$2.91M–
Q2 FY2025Jun 30, 2025-$2.90M–
Q1 FY2025Mar 31, 2025-$2.42M–
Q4 FY2024Dec 31, 2024-$2.88M–
Q3 FY2024Sep 30, 2024-$2.47M–
Q2 FY2024Jun 30, 2024-$2.39M–
Q1 FY2024Mar 31, 2024-$1.08M–
Q4 FY2023Dec 31, 2023-$3.23M–
Q3 FY2023Sep 30, 2023-$1.42M–
Q2 FY2023Jun 30, 2023-$2.33M–
Q1 FY2023Mar 31, 2023-$3.26M–
Q4 FY2022Dec 31, 2022-$2.16M–
Q3 FY2022Sep 30, 2022-$2.14M–
Q2 FY2022Jun 30, 2022-$2.59M–
Q1 FY2022Mar 31, 2022-$3.00M–
Q4 FY2021Dec 31, 2021-$2.36M–
Q3 FY2021Sep 30, 2021-$1.51M–
Q2 FY2021Jun 30, 2021-$1.31M–
Q1 FY2021Mar 31, 2021-$1.15M–
Q4 FY2020Dec 31, 2020-$878.00K–
Q3 FY2020Sep 30, 2020-$1.10M–
Q2 FY2020Jun 30, 2020-$773.00K–
Q1 FY2020Mar 31, 2020-$1.05M–

More RenovoRx figures

See a number that looks wrong?